Artivion (AORT 1.33%), a leader in cardiac and vascular surgical devices, reported its Q2 2025 results on August 7, 2025. The company posted non-GAAP earnings per share of $0.24, outperforming the analyst estimate of approximately -$0.00 (non-GAAP) and marking a sharp increase from $0.07 per share (non-GAAP) in Q2 2024. Revenue (GAAP) came in at$113.0 million, ahead of the $108.03 million non-GAAP consensus estimate and 15% above the prior-year figure (GAAP). Management described the period as a standout q ...